The impact of donor viral replication at transplant on recipient infections posttransplant: A prospective study

Transplantation

Volumn 99, Issue 3, 2015, Pages 602-608

  Verghese, Priya S ^a   Schmeling, David O ^a   Knight, Jennifer A ^a   Matas, Arthur J ^a   Balfour, Henry H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BK VIRUS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GRAFT RECIPIENT; HUMAN; INFECTION RISK; KIDNEY GRAFT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; ORGAN DONOR; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SURVIVAL; VIREMIA; VIRUS REPLICATION; ADVERSE EFFECTS; CHILD; COMPLICATION; CYTOMEGALOVIRUS INFECTION; DONOR; EPSTEIN BARR VIRUS INFECTION; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYOMAVIRUS INFECTION; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; VIRUS REPLICATION; YOUNG ADULT;

EID: 84942791755     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000354     Document Type: Article

References (29)

1. Li L, Chaudhuri A, Weintraub LA, Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11: 187
2. Smith JM, Corey L, Bittner R, Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J Am Soc Nephrol 2010; 21: 1579
3. Bamoulid J, Courivaud C, Coaquette A, Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences. Am J Transplant 2013; 13: 656
4. Taylor AL, Marcus R, Bradley JA,. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005; 56: 155
5. Kaden J, Zenker S, Eichler C, Risk of CMV infection and illness after kidney transplantation. Allerg Immunol (Leipz) 1991; 37: 47
6. Ho M, Suwansirikul S, Dowling JN, The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 1975; 293: 1109
7. Cen H, Breinig MC, Atchison RW, Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 1991; 65: 976
8. Balfour HH Jr, Slade MS, Kalis JM, Viral infections in renal transplant donors and their recipients: a prospective study. Surgery 1977; 81: 487
9. Bohl DL, Storch GA, Ryschkewitsch C, Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213
10. Saundh BK, Baker R, Harris M, Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy. J Infect Dis 2013; 207: 137
11. Hirsch HH, Steiger J, Polyomavirus BK,. Lancet Infect Dis 2003; 3: 611
12. Barzon L, Murer L, Pacenti M, Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients. J Infect Dis 2009; 200: 1425
13. Sood P, Senanayake S, Sujeet K, Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study. Transplantation 2013; 95: 896
14. Egli A, Infanti L, Dumoulin A, Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837
15. Knowles WA, Pipkin P, Andrews N, Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115
16. Hirsch HH, Brennan DC, Drachenberg CB, Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277
17. De la Torre-Cisneros J, Farinas MC, Caston JJ, GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011; 29: 735
18. Sixbey JW, Vesterinen EH, Nedrud JG, Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 1983; 306: 480
19. Li QX, Young LS, Niedobitek G, Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 1992; 356: 347
20. Behzad-Behbahani A, Klapper PE, Vallely PJ, Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 2004; 29: 224
21. Ling PD, Lednicky JA, Keitel WA, The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003; 187: 1571
22. Elfadawy N, Flechner SM, Liu X, CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Transplantation 2013; 96: 1097
23. Lopez-Oliva MO, Martinez V, Buitrago A, Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant. Transplantation 2014; 97: 839
24. McDevitt LM,. Etiology and impact of cytomegalovirus disease on solid organ transplant recipients. Am J Health Syst Pharm 2006; 63 (19 Suppl 5): S3
25. Cantisan S, Torre-Cisneros J, Lara R, Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation. J Gerontol A Biol Sci Med Sci 2013; 68: 1
26. Roman A, Manito N, Campistol JM, The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Transplantat Rev 2014; 28: 84
27. Balfour HH Jr, Odumade OA, Schmeling DO, Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 2013; 207: 80
28. Schachtner T, Muller K, Stein M, BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant 2011; 11: 2443
29. Ginevri F, Azzi A, Hirsch HH, Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727